LETTER TO THE EDITOR
|Year : 2017 | Volume
| Issue : 4 | Page : 434-435
A sibling pair with autosomal recessive Charcot–Marie–Tooth disease due to novel ganglioside-induced differentiation-associated protein 1 mutation
Poornima Amit Shah1, Amit M Shah2
1 Department of Clinical Neurophysiology, Jaslok Hospital, Mumbai, Maharashtra, India
2 Department of Neurology, Criticare Hospital, Mumbai, Maharashtra, India
|Date of Web Publication||25-Oct-2017|
Poornima Amit Shah
Department of Clinical Neurophysiology, 2nd Floor, Jaslok Hospital and Research Centre, 15, Dr. G. Deshmukh Marg, Mumbai - 400 026, Maharashtra
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Shah PA, Shah AM. A sibling pair with autosomal recessive Charcot–Marie–Tooth disease due to novel ganglioside-induced differentiation-associated protein 1 mutation. Ann Indian Acad Neurol 2017;20:434-5
|How to cite this URL:|
Shah PA, Shah AM. A sibling pair with autosomal recessive Charcot–Marie–Tooth disease due to novel ganglioside-induced differentiation-associated protein 1 mutation. Ann Indian Acad Neurol [serial online] 2017 [cited 2021 Oct 27];20:434-5. Available from: https://www.annalsofian.org/text.asp?2017/20/4/434/217173
Charcot–Marie–Tooth disease (CMT) due to ganglioside-induced differentiation-associated protein 1 (GDAP1) mutations is rare. The GDAP1 expression in the Schwann cells and in the outer mitochondrial membrane is responsible for the complex interplay whereby it can cause axonal as well as demyelinating neuropathy. Although GDAP1 is also expressed in the brain, no clinical involvement has been documented so far in any patient. The purpose of this letter is to report an Indian family with a novel GDAP1 mutation which also appears to be the first report in literature.
The index case was a 12-year-old boy with delayed motor milestones, bilateral foot drop, and frequent falls. At presentation, he was ambulatory independently, but he had been using ankle orthoses for few years. On examination, there was distal wasting in a length-dependent manner without sensory loss, hypotonia, and diffuse areflexia. Higher mental functions and cranial nerves were intact. No dysmorphism was noted. Electrodiagnostic (EDX) study suggested a generalized sensorimotor mixed, i.e., axonal and demyelinating type of polyneuropathy, with severe active denervation in the right tibialis anterior. Family history was relevant for his 14-year-old sister who had a similar clinical and EDX profile. On screening, the father had attenuated superficial peroneal sensory nerve action potential amplitude (3–4 uV). Both parents showed a reduced sural: radial SNAP amplitude ratio suggestive of sensory axonopathy affecting the feet. The siblings showed a homozygous missense variation c. 3G>A.p in the start codon of GDAP1 gene and both parents showed a heterozygous mutation for the same. The start codon mutation would abolish the protein translation causing complete loss of GDAP1 function. [Table 1] is a summary of the clinical, EDX, and genetic profile of the family.
|Table 1: Summary of the clinical, electrodiagnostic, and genetic profile of the family|
Click here to view
In the evaluation of children with early foot deformities and delayed motor milestones without a significant history during birth and neonatal period, testing for FGD4, PRX, MTMR2, SBF2, SH3TC2, and GDAP1 was recommended by Baets et al. The three most common genes associated with autosomal recessive CMT are GDAP1, SH3TC2, and HINT1, GDAP1 being the most frequent., Mutations in the GDAP1 can occur with dominant and recessive inheritance patterns. The early onset and severe phenotype in the siblings with unaffected parents and negative family history suggest an autosomal recessive mode of inheritance. Since both parents showed early sensory axonopathy affecting the lower limbs, it may be appropriate to postulate that the demyelination seen in the siblings may be secondary to axonal degeneration.
The diagnostic protocol for a suspected recessive inheritance pattern suggests initial screening for mutations in NDRG1 which is responsible for CMT4D. If negative or if not of Gypsy ethnicity, then screening for GDAP1 is recommended.
CMT is genetically and clinically heterogeneous. Careful attention to phenotype combined with good electrophysiological evaluation of patient and unaffected parents helped us to narrow the diagnosis to the possible subtype.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Baets J, Deconinck T, De Vriendt E, Zimoń M, Yperzeele L, Van Hoorenbeeck K, et al.
Genetic spectrum of hereditary neuropathies with onset in the first year of life. Brain 2011;134:2664-76.
Meuleman J, Pou-Serradell A, Löfgren A, Ceuterick C, Martin JJ, Timmerman V, et al.
A novel 3'-splice site mutation in peripheral myelin protein 22 causing hereditary neuropathy with liability to pressure palsies. Neuromuscul Disord 2001;11:400-3.
Nelis E, Erdem S, Van Den Bergh PY, Belpaire-Dethiou MC, Ceuterick C, Van Gerwen V, et al.
Mutations in GDAP1: Autosomal recessive CMT with demyelination and axonopathy. Neurology 2002;59:1865-72.
Berciano J, Sevilla T, Casasnovas C, Sivera R, Vílchez JJ, Infante J, et al.
Guidelines for molecular diagnosis of Charcot-Marie-Tooth disease. Neurologia 2012;27:169-78.